Cas 474970-23-5,[4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide

474970-23-5

Post Buying Request

Basic information

Product Name: [4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide
Synonyms: [4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide
CAS NO:474970-23-5
Molecular Formula:
Molecular Weight: 571.936
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(CAS DataBase Reference)
NIST Chemistry Reference: [4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(474970-23-5)
EPA Substance Registry System: [4-(4-chloro-3-nitrophenyl)thiazol-2-ylthio]-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(474970-23-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 474970-23-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

474970-23-5 Suppliers

Recommended suppliers

474970-23-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 474970-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,4,9,7 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 474970-23:
(8*4)+(7*7)+(6*4)+(5*9)+(4*7)+(3*0)+(2*2)+(1*3)=185
185 % 10 = 5
So 474970-23-5 is a valid CAS Registry Number.

474970-23-5Upstream product

474970-23-5Downstream Products

474970-23-5Relevant academic research and scientific papers

NOVEL BENZYLPIPERIDINE COMPOUND

-

Page 35, (2010/02/05)

The object of the present invention is to provide a compound having a treatment effect based on a chemokine inhibitory activity, which is satisfactory as a pharmaceutical product for oral administration. The present inventors have found that the following

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 474970-23-5